Clinical Trial Update: A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs) [Phase 2]

View source ↗

Summary

Phase II trial evaluating the efficacy and safety of HRS9950 tablets in chronic hepatitis B patients virologically suppressed on nucleoside or nucleotide analog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HRS9950 (HRS9950)

Snippet

Sponsor: Chengdu Suncadia Medicine Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED